Answers are grounded in this paper and cite their sources.
Phase IB NABUCCO study analyzes patient responses by molecular subtype, showing distinct outcomes based on treatment groups.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Stockem et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: